Top

Published in:

01-02-2020 | Sunitinib | Editorial

2019 SEOM guidelines (the end of a decade)

Authors: A. González-del-Alba, Á. Rodríguez-Lescure

Published in: Clinical and Translational Oncology | Issue 2/2020

Excerpt

We present a new edition of the Spanish Society of Medical Oncology guidelines focused on reviewing the available evidence regarding the management of diagnosis and treatment in different tumors. Beyond the scope of a comprehensive review, the purpose of these guidelines is to provide an eminently practical view of the most relevant considerations with respect to the various cancer-related scenarios. …

Muñoz Martín AJ, Gallardo Díaz E, García Escobar I, Macías Montero R, Martínez-Marín V, Pachón Olmos V, et al. SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019). Clin Trans Oncol. 2019. https://doi.org/10.1007/s12094-019-02263-z.CrossRef

Santaballa A, Pinto Á, Porta Balayà R, Ramírez Merino N, Ruiz Martín I, Saura Grau S, et al. SEOM clinical guideline for secondary prevention (2019). Clin Trans Oncol. 2020. https://doi.org/10.1007/s12094-020-02302-0.CrossRef

González-Santiago S, Ramón y Cajal T, Aguirre E, Alés-Martínez JE, Andrés R, Balmaña J, et al. SEOM clinical guidelines in hereditary breast and ovarian cancer (2019). Clin Transl Oncol. 2019. https://doi.org/10.1007/s12094-019-02262-0.CrossRefPubMedPubMedCentral

Guillén-Ponce C, Lastra E, Lorenzo-Lorenzo I, Martín Gómez T, Morales Chamorro R, Sánchez-Heras AB, et al. SEOM clinical guideline on hereditary colorectal cancer (2019). Clin Transl Oncol. 2019. https://doi.org/10.1007/s12094-019-02272-y.CrossRefPubMed

Majem M, García-Martínez E, Martinez M, Muñoz-Couselo E, Rodríguez-Abreu D, Álvarez R, et al. SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019). Clin Transl Oncol. 2019. https://doi.org/10.1007/s12094-019-02273-x.CrossRefPubMedPubMedCentral

Gallardo E, Medina J, Sánchez JC, Viúdez A, Grande E, Porras I, et al. SEOM clinical guideline thyroid cancer (2019). Clin Transl Oncol. 2019. https://doi.org/10.1007/s12094-019-02284-8.CrossRefPubMedPubMedCentral

Martín-Richard M, Carmona-Bayonas A, Custodio AB, Gallego J, Jiménez-Fonseca P, Reina JJ, et al. SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019). Clin Transl Oncol. 2019. https://doi.org/10.1007/s12094-019-02259-9.CrossRef

Dómine M, Morán Bueno T, Isla D, Marti JL, Sullivan I, Provencio M, et al. SEOM clinical guidelines for the treatment of Small-cell lung cancer (SCLC). Clin Transl Oncol. 2020. https://doi.org/10.1007/s12094-020-02295-w.CrossRefPubMed

Lázaro M, Valderrama BP, Suárez C, de-Velasco G, Beato C, Chirivella I, et al. SEOM clinical guideline for treatment of kidney cancer (2019). Clin Trans Oncol. 2019. https://doi.org/10.1007/s12094-019-02285-7.CrossRef

10.

de Juan A, Redondo A, Rubio MJ, García Y, Cueva J, Gaba L, et al. SEOM clinical guidelines for cervical cancer (2019). Clin Trans Oncol. 2019. https://doi.org/10.1007/s12094-019-02271-z.CrossRef

Title: 2019 SEOM guidelines (the end of a decade)
Authors: A. González-del-Alba
Á. Rodríguez-Lescure
Publication date: 01-02-2020
Publisher: Springer International Publishing
Keyword: Sunitinib
Published in: Clinical and Translational Oncology / Issue 2/2020
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-020-02309-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2020

SEOM clinical guideline for secondary prevention (2019)

SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)

SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019)

SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)

SEOM clinical guidelines for cervical cancer (2019)

SEOM clinical guidelines in hereditary breast and ovarian cancer (2019)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer